Novartis Faces Legal Hurdle as Court Denies Dismissal in Trade Secret Dispute with Hedge Fund
In a recent judicial development, the pharmaceutical giant Novartis has been dealt a setback in a legal battle involving trade secret allegations. A New York federal judge denied Novartis’ motion to dismiss a lawsuit brought by an investment management firm. This firm has accused the company, among others, of conspiring with its former chief investment…